Analytical Data
-
Gene name
SLAMF2
- Application
-
Alternative Names
SLAMF2；BCM1；CD48 antigen
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09326
-
Expression Region
27-220aa
-
AA Sequence
QGHLVHMTVVSGSNVTLNISESLPENYKQLTWFYTFDQKIVEWDSRKSKY FESKFKGRVR LDPQSGALYISKVQKEDNSTYIMRVLKKTGNEQEWKIK LQVLDPVPKPVIKIEKIEDMDD NCYLKLSCVIPGESVNYTWYGDKRPF PKELQNSVLETTLMPHNYSRCYTCQVSNSVSSKN GTVCLSPPCTLARS
-
Molecular Weight
23 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLAMF2, a member of the SLAM (Signaling Lymphocytic Activation Molecule) family, is an immunoglobulin-like receptor primarily expressed on immune cells, including T cells and B cells. This protein plays a critical role in modulating immune responses, influencing both activation and inhibition of lymphocyte functions. Research has shown that SLAMF2 is involved in various pathological conditions, including autoimmune diseases and viral infections, making it a target of interest for therapeutic interventions. As a receptor that interacts with different ligands, the functional study of SLAMF2 and its signaling pathways is essential for understanding its role in immune regulation. The development of recombinant SLAMF2 proteins facilitates the exploration of its structural and functional properties, allowing researchers to investigate the mechanisms by which it influences immune cell behavior. Furthermore, recombinant SLAMF2 can be used in laboratory settings to generate antibodies or as a part of vaccine development strategies, highlighting its potential for clinical applications. Investigating SLAMF2's role in immune responses not only enhances our understanding of its biology but also contributes to the development of targeted therapies for immune-related disorders.
